ScanMed Brings Prostate/Pelvic MRI Coil for Prostate Cancer Detection to the Masses on CBS Action News 3

News provided by

Aug 19, 2015, 10:03 ET

OMAHA, Neb., Aug. 19, 2015 /PRNewswire/ -- ScanMed, LLC CEO Dr. Randall Jones (PhD, MBA) introduces Prostate/Pelvic MRI Coil dedicated to prostate cancer detection on Omaha's CBS Action News 3 segment "The Morning Blend."

Watch as ScanMed's CEO Dr. Randall Jones (PhD, MBA) introduces Prostate/Pelvic MRI Coil dedicated to prostate cancer detection on Omaha's CBS Action News 3 segment "The Morning Blend."

The landscape of prostate cancer awareness, detection, and diagnosis is rapidly changing, and the Omaha-based MRI coil (anatomically specific MRI antennae) company, ScanMed, is leading the way. ScanMed introduces innovative, solution-based MRI coils to the market as well as provides MRI Coil Repair, Refurbishment, Engineering, Manufacturing, and Online Coil Commerce services. To learn more, visit http://www.scanmed.com.

ScanMed CEO, Dr. Randall "Randy" Jones, saw the opportunity to improve prostate cancer detection in 2011, and dedicated his Research and Design team to the creation of the Prostate/Pelvic Coil. His main goal was to make affordable, non-invasive diagnostic options available to the masses, as he explained this summer to "The Morning Blend" team Mike DiGiacomo and Mary Nelson.

Jones informed the interviewers that the only technology available has been general torso coils, which don't have enough sensitivity to detect cancers, and the endorectal probe, an invasive coil that has given male patients considerable pause (or denial) when it comes to their diagnostic options. Jones believes that this wearable MRI coil will rapidly change this paradigm.

Jones recommends that patients 40+ years old get their PSA (Prostate Specific Antigen) test, as it can be a valid early-warning indicator. If the PSA indicates anything out of the ordinary, he then recommends looking at procedures like MRI instead of turning immediately to a "blind" biopsy, which produces approximately 50% false negative results and can cause damage to the prostate organ. The key to success is the early detection that the Prostate/Pelvic Coil can provide in conjunction with advanced MRI techniques. Jones points out that in terms of later detection, typically the only treatment option presented is total removal of the organ. This typically results in incontinence, impotence, or both.

Some of the world's top 25 research institutions are currently using the Prostate/Pelvic Coil, including UCLA, Mayo Clinic, Duke University, and Radboud Prostate MR-Reference Center, Netherlands. Jones, in collaboration with healthcare providers, plans to bring this technology locally at a price affordable to the masses.

Sales Contact
Marie Schuett
Marketing Manager
ScanMed, LLC
9840 S. 140^th Street, Suite 8, Omaha, NE 68138
Office (402) 934-2650
[email protected]

Video - http://youtu.be/K0rnetog15I

SOURCE ScanMed, LLC